1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adaptive Biotechnologies Corporation (ADPT)

  7. Adaptive Biotechnologies Corporation (ADPT) Financials

ADPT

Adaptive Biotechnologies Corporation
8.33
0.09 (1.09%)
Upgrade to Real-Time

Adaptive Biotechnologies Corporation (ADPT) Fundamentals
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease ("MRD") in patients with multiple myeloma ("MM"), B cell acute lymphoblastic leukemia ("ALL") and chronic lymphocytic leukemia ("CLL") and is also available as a CLIA-validated laboratory developed test ("LDT") for patients with other lymphoid cancers, including diffuse large B-cell lymphoma ("DLBCL").
SHARE INFORMATION
Market CapUS$ 1,180,188,478
Shares Outstanding143,226,757
Float97,332,166
Percent Float67.96%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 185,308,000
Latest Fiscal EPSUS$ -1.41
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions540
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months14,164,934
Institutional Holdings Percent153.0%
Institutional Sold Previous 3 Months24,548,532
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months53,000
Insider Holdings Percent5.0
Insider Sold Previous 3 Months56,125
Insider Shares Owned7,166,010
TRADING INFO
52 Week HighUS$ 15.19
52 Week LowUS$ 5.96
52 Week High ChangeUS$ -36.27
21 Day Moving AverageUS$ 8.3367
21 Day Extended Moving AverageUS$ 8.3786
50 Day Moving AverageUS$ 8.8416
50 Day Extended Moving AverageUS$ 8.5408
200 Day Moving AverageUS$ 8.6045
200 Day Extended Moving AverageUS$ 10.0333
10 Day Average Volume783,467
20 Day Average Volume831,445
30 Day Average Volume959,916
50 Day Average Volume951,692
Alpha-0.032557
Beta1.1729
Standard Deviation0.171236
R20.149063
7 Day Price ChangeUS$ -0.11
7 Day Percent Change-1.32%
21 Day Price ChangeUS$ -0.36
21 Day Percent Change-4.19%
30 Day Price ChangeUS$ -0.31
30 Day Percent Change-3.63%
Month to Date Price ChangeUS$ -0.31
Month to Date Percent Change-3.63%
Quarter to Date Price ChangeUS$ 0.60
Quarter to Date Percent Change7.85%
180 Day Price ChangeUS$ 1.12
180 Day Percent Change15.73%
200 Day Price ChangeUS$ -0.67
200 Day Percent Change-7.52%
Year to Date Price ChangeUS$ 0.60
Year to Date Percent Change7.85%

Adaptive Biotechnologies Corporation (ADPT) Key Ratios

PROFITABILITY
EBIT Margin-132.5%
EBITDA Margin-120.3%
Pre-Tax Profit Margin-116.5%
Profit Margin Count0.0%
Gross Margin68.8%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 185,308,000
Revenue Per ShareUS$ 1.2938
Revenue (3 Years)US$ 32.13
Revenue (5 Years)US$ 30.69
FINANCIAL STRENGTH
Price to Tangible Book3.60
Total Debt To Equity0.20
Int Coverage-46.30
Current Ratio5.10
Leverage Ratio1.70
Quick Ratio4.90
Long Term Debt To Capital0.18
VALUATION MEASURES
PE Ratio40.60
Enterprise ValueUS$ 817,207,561
Price to Sales6.3688
Price to Free Cash-6.00
PE High Last 5 Years0.00
Price To Book2.60
Price To Cash Flow10.80
PE Low Last 5 Years0.00
Price to Tangible Book3.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover6.30
Invoice Turnover2.40
Assets Turnover0.20
Return Assets-23.18
Return on Equity-38.72
Return on Capital-32.78

Adaptive Biotechnologies Corporation (ADPT) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOChad Robins
Emplyoees790
Last AuditUQ
CIK0001478320
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1165 Eastlake Avenue East
Suite 200
Seattle, WA 98109
Websitehttps://www.adaptivebiotech.com
Facsimile+1 206 659-0667
Telephone+1 206 659-0067
Email-
Your Recent History
NASDAQ
ADPT
Adaptive B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230329 14:02:17